Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

276 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Biomodulatory metronomic therapy in stage IV melanoma is well-tolerated and may induce prolonged progression-free survival, a phase I trial.
Hart C, Vogelhuber M, Hafner C, Landthaler M, Berneburg M, Haferkamp S, Herr W, Reichle A. Hart C, et al. J Eur Acad Dermatol Venereol. 2016 Nov;30(11):e119-e121. doi: 10.1111/jdv.13391. Epub 2015 Sep 29. J Eur Acad Dermatol Venereol. 2016. PMID: 26417987 Free PMC article. Clinical Trial. No abstract available.
Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab.
Brüggemann C, Kirchberger MC, Goldinger SM, Weide B, Konrad A, Erdmann M, Schadendorf D, Croner RS, Krähenbühl L, Kähler KC, Hafner C, Leisgang W, Kiesewetter F, Dummer R, Schuler G, Stürzl M, Heinzerling L. Brüggemann C, et al. J Cancer Res Clin Oncol. 2017 Oct;143(10):1977-1984. doi: 10.1007/s00432-017-2450-2. Epub 2017 Jun 14. J Cancer Res Clin Oncol. 2017. PMID: 28616701 Clinical Trial.
Identification of differentially expressed genes in models of melanoma progression by cDNA array analysis: SPARC, MIF and a novel cathepsin protease characterize aggressive phenotypes.
Rumpler G, Becker B, Hafner C, McClelland M, Stolz W, Landthaler M, Schmitt R, Bosserhoff A, Vogt T. Rumpler G, et al. Exp Dermatol. 2003 Dec;12(6):761-71. doi: 10.1111/j.0906-6705.2003.00082.x. Exp Dermatol. 2003. PMID: 14714555
Therefore, we investigated siblings of cell lines or malignant melanomas (MM), which have been selected by nude mouse passages for (a). increased tumorigenicity (local ECM-independent growth), (b). metastatic potential, or (c). selected for increase invasiveness using the …
Therefore, we investigated siblings of cell lines or malignant melanomas (MM), which have been selected by nude mouse passages for (a). incr …
[Treatment of metastatic melanoma with BRAF inhibitors].
Hafner C. Hafner C. Hautarzt. 2011 Sep;62(9):696-8. doi: 10.1007/s00105-011-2232-8. Hautarzt. 2011. PMID: 21863388 German. No abstract available.
[Treatment of metastatic melanoma with CTLA4 antibodies].
Hafner C. Hafner C. Hautarzt. 2010 Sep;61(9):808-10. doi: 10.1007/s00105-010-2033-5. Hautarzt. 2010. PMID: 20721523 German. No abstract available.
Somatic FGFR3 and PIK3CA mutations are present in familial seborrhoeic keratoses.
Hafner C, Vogt T, Landthaler M, Müsebeck J. Hafner C, et al. Br J Dermatol. 2008 Jul;159(1):214-7. doi: 10.1111/j.1365-2133.2008.08626.x. Epub 2008 Jul 1. Br J Dermatol. 2008. PMID: 18503601
276 results
Jump to page
Feedback